Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Thermo Fisher Scientific acquires Patheon

Thermo Fisher Scientific Inc. snapped up North Carolina-based Patheon N.V. in a deal valued at $7.2 billion.

Read More »

Biotech Loses a Legend: Genzyme Founder and Longtime CEO Dies at 71

Biotech innovator Henri Termeer, the longtime chief executive officer of Genzyme and a pioneer in orphan drug development, passed away at the age of 71 years.

Read More »

Vaccine alliance says 300,000 doses of Merck’s Ebola shot available for emergencies

The GAVI global vaccine alliance said some 300,000 emergency doses of an Ebola vaccine developed by Merck could be available in case of a large-scale outbreak, after the World Health Organization confirmed a fatal case in Congo.

Read More »

Migraine drug meets main late-stage studies goal

Patients with episodic and chronic migraine reported fewer debilitating headaches after using Eli Lilly’s experimental drug compared to those on placebo.

Read More »

Durvalumab reduces risk of death from lung cancer

A trial of AstraZeneca’s key immunotherapy drug durvalumab showed it reduced the risk of death from advanced lung cancer.

Read More »

SoCal’s Capricor to Reduce Workforce and Shift Focus After Discouraging Trial Results

Shares of Capricor Therapeutics plunged nearly 60 percent in premarket trading after the company announced it was laying off an unknown number of employees following the failure of a mid-stage cardiovascular drug trial.

Read More »

Top GlaxoSmithKline Investor Cashes Out, Citing a Weak Pipeline and Lack of Strategic Options

Neil Woodford, of UK’s Woodford Investment Management, unloaded his company’s shares of London-based GlaxoSmithKline. His concerns include a weak pipeline and few strategic options.

Read More »

U.S. candymakers band together to reduce calories

Five major chocolate and candy companies announced a joint commitment to reduce calories in many sweets sold on the U.S. market, a rare example of cooperation in a competitive industry and testament to a rising consumer distaste for sugar.

Read More »

WHO wants transparency, market revamp for fairer drug pricing therape

The world needs greater transparency on the pricing of medicines – and an overhaul of some approaches – in order to increase access to life-saving drugs, global health experts said.

Read More »

Digitas Health Names John Mangano to Lead Strategy and Analytics Practice

John Mangano was named senior VP, Strategy and Analytics, at Digitas Health – the Agency of Now.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom